You are here

Disable VAT on Taiwan

Unfortunately, as of 1 January 2020 SAGE Ltd is no longer able to support sales of electronically supplied services to Taiwan customers that are not Taiwan VAT registered. We apologise for any inconvenience. For more information or to place a print-only order, please contact uk.customerservices@sagepub.co.uk.

Therapeutic Advances in Chronic Disease

Therapeutic Advances in Chronic Disease


eISSN: 20406231 | ISSN: 20406223 | Current volume: 14 | Current issue: 1 Frequency: Yearly
Journal Highlights 
  • Launched in 2010
  • Gold open access journal – all articles are made freely available online immediately upon publication
  • Rigorous peer review
  • Listed in PubMed and indexed in Web of Science, Science Citation Index Expanded (SCIE) and Scopus
  • Reaches a broad, multidisciplinary audience
  • Over 600 000 full-text article views annually
Therapeutic Advances in Chronic Disease (TACD) is a peer-reviewed open access journal which focuses on the highest quality research, reviews and scholarly comment on pioneering efforts and innovative studies across all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers, providing a forum in print and online for publishing the highest quality articles in this area. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).


Diversity, Equity and Inclusion Statement

Therapeutic Advances in Chronic Disease (TACD) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the chronic disease community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.


Submission information
Submit your manuscript today at http://mc.manuscriptcentral.com/tacd
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.


Open access article processing charge (APC) information

Unsolicited manuscripts submitted to Therapeutic Advances in Chronic Disease are currently subject to an Article Processing Charge (APC) of 2800 USD payable upon acceptance. These articles will be published under a Creative Commons licence and will be made openly available. 

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Contact

Please direct any queries to TAChronicDisease@sagepub.com.

Therapeutic Advances in Chronic Disease delivers the highest quality peer-reviewed, open access, original research articles, reviews, and scholarly comment on pioneering efforts across all areas of chronic disease. The journal has a strong clinical focus and is aimed at an international audience of clinicians, researchers, and allied health practitioners in chronic disease, providing an online forum for rapid dissemination of recent research and perspectives in this area. The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.

Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, health-economic and pharma-economic reviews are also welcomed. The appropriate EQUATORnetwork reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of the first patient enrolment.

Managing Editor
Hemali Bedi SAGE Publications Ltd, London, UK
Gayatri More SAGE Publishing, New Delhi, India
Associate Editor - Cardiology
Stephen Hoole Royal Papworth Hospital, Cambridge, UK
Associate Editor - Dermatology
Lluís Puig Universitat Autònoma de Barcelona, Barcelona, Spain
Associate Editor - Endocrinology
Thozhukat Sathyapalan University of Hull, Kingston upon Hull, UK
Associate Editor - Gastroenterology
Ian Beales Norfolk and Norwich University Hospital, Norfolk, UK
Associate Editor - Nephrology
Ashish Verma Boston University Chobanian & Avedisian School of Medicine, Boston, USA
Associate Editor - Neurology
Jan Kassubek University of Ulm, Ulm, Germany
Associate Editor – Rheumatology
Pankaj Bansal Mayo Clinic College of Medicine, Wisconsin, USA
Associate Editor - Respiratory
Lucia Spicuzza University of Catania, Catania, Italy
Associate Editor – Hepatology
Liang Qiao The University of Sydney, Westmead, Australia
Biostatistical Editors
Ram Bajpai School of Medicine, Keele University, UK
Editorial Board
Kathryn Abel University of Manchester, Manchester, UK
Bo Abrahamsen Copenhagen University Hospital Gentofte, Hellerup, Denmark
Frazer H Anderson Southampton University, UK
Riitta Antikainen Oulu City Hospital, Oulu, Finland
Jianfeng Bao Hangzhou Xixi Hospital, Zhejiang University School Of Medicine, Hangzhou, China
Mainak Bardhan Miami Cancer Institute, Florida, FL, USA
Srikanth Bellary Aston University, Birmingham, UK
Michael Berk University of Melbourne, Australia
Michael Blackburn University of Texas, USA
Xavier Calvet Hospital de Sabadell, Spain
Gemma Casadesus Case Western Reserve University, USA
Rudolph Castellani University of Maryland, MD, USA
Mario Cazzola University of Rome "Tor Vergata", Rome, Italy
Pascal Chanez University of the Mediterranian, Marseille, France
Martin Connolly University of Auckland, New Zealand
Leonardo M. Fabbri University of Modena and Reggio Emilia, Italy
Serge Ferrari Hopitaux Universitaires de Geneve, Switzerland
Stephen Gallacher Southern General Hospital, Glasgow, Scotland
Javier P. Gisbert La Princesa University Hospital, Madrid, Spain
Neil Gittoes Queen Elizabeth Hospital, Birmingham, UK
Mugdha Gokhale Pfizer, Collegeville and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA
Nicola Hanania Baylor College of Medicine, Houston, TX, USA
Zhen Hong, MD, PhD West China Hospital, Sichuan University, Sichuan, China
Elaine Hylek Boston Medical Center, Boston, MA, USA
Chunmeng Jiang Dalian Medical University 2nd Hospital, Dalian, Liaoning, China
Peter Joyce Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
Matthew C. Kiernan Brain and Mind Centre, University of Sydney, Australia
Sarah Kingsbury Chapel Allerton Hospital, Leeds, UK
Constantine E. Kosmas National and Kapodistrian University of Athens, University General Hospital “ATTIKON”, Athens, Greece
Anastasios Koulaouzidis University of Southern Denmark, Denmark
Hyoung-gon Lee Case Western Reserve University, Cleveland, OH, USA
Yiling Li Department of Gastroenterology and Hepatology, The First Hospital of China Medical University, Shenyang, Liaoning, China
Ricardo Maccioni University of Chile Medical School, Chile
Mario Malerba University of Eastern Piedmont, Vercelli, Italy
Marco Manfredini University of Modena and Reggio Emilia, Modena, Italy
Arduino Mangoni Flinders Medical Centre and Flinders University, Bedford Park, Australia
Tahir Masud Nottingham University, Nottingham, UK
Eugene McCloskey University of Sheffield, Sheffield, UK
Terry McCormack Whitby Medical Practice, UK
Andrew McIntosh University of Edinborgh, UK
Francesco Menzella AULSS2 Marca Trevigiana, Italy
Paula Moreira University of Coimbra, Portugal
Jaymin Morjaria Harefield Hospital, UK
Bjorn Moum Faculty Div. Aker University Hospital, Norway
Yuemin Nan Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Hebei, China
Anthony O'Connor Adelaide and Meath Hospital, Ireland
Pierluigi Paggiaro University of Pisa, Pisa, Italy
Sanjeev Patel St Helier University Hospital, Carshalton, UK
George Perry The University of Texas at San Antonio, USA
Ruth Peters Imperial College, London, UK
Riccardo Polosa Az. Ospedaliero-Universitaria Vittorio Emanuele, Catania, Italy
James Potash Mood Disorders Centre, Baltimore, USA
Beatrice Ragnoli S.Andrea Hospital- University of Eastern Piedmont, Vercelli, Italy
Huiying Rao Hepatology Institute, Peking University People’s Hospital, Beijing, China
Marianne Uggen Rasmussen The Parker Institute, Copenhagen University Hospital, Denmark
Craig Ritchie University of Edinburgh, UK
Francesco Roselli Ulm University and DZNE-Ulm, Ulm, Germany
Gaetano Santulli, MD, PhD Albert Einstein College of Medicine, New York City, NY, USA
Thomas Schulze Georg-August-University Göttingen, Germany
Monish Sheth Baylor College of Medicine, Temple, TX, USA
Shun Shinohama Sapporo Medical University, Japan
Massimo Tabaton University of Genoa, Genoa, Italy
Professor Rajesh Tampi, MD, MS Yale School of Medicine, New Haven, CT, USA & Creighton University School of Medicine, Omaha, NE, USA
Ahmed Tawheed Helwan University, Cairo, Egypt
Irina Turchin Brunswick Dermatology Center, Fredericton, Canada
Hua Wang Institute for Liver Disease, First Affiliated Hospital of Anhui Medical University, Anhui, China
Lakshmi Yatham University of British Columbia, Canada
Junmin Zhang Lanzhou University, Lanzhou, China
Ming-Hua Zheng MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
Xiongwei Zhu Case Western Reserve University, USA
Editorial Review Board
Brent Gawey, MD, MSc Mayo Clinic (Rochester, MN), USA
Sneha S. Pillai, PhD Marshall University, USA
Kiran K Upadhyay ,MD University of Florida, USA
Luyu Xie University of Texas, USA
  • Clarivate Analytics: Current Contents - Clinical Medicine
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Directory of Open Access Journals (DOAJ)
  • ProQuest
  • PubMed Central (PMC)
  • Scopus
  • Manuscript submission guidelines can be accessed on Sage Journals.